Company Search:
Advanced Search
Sponsored Links
Wuxi Biologics Cayman Inc Company Snapshot
Wuxi Biologics Cayman Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Wuxi Biologics Cayman Inc with three other pharmaceutical manufacturers in Asia: Tianjin Ringpu Bio-Technology Co Ltd of China (2016 sales of 969.68 million Chinese Renmimbi [US$153.38 million] of which 63% was Veterinary Biological Products), Beijing SL Pharmaceutical Co Ltd of China (1.01 billion Chinese Renmimbi [US$159.74 million] of which 98% was Pharmaceuticals Industry), and Boya Bio-pharmaceutical Group Co Ltd which is also based in China (946.57 million Chinese Renmimbi [US$149.73 million] of which 56% was Blood Plasma).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Wuxi Biologics Cayman Inc
  Stock Performance Chart for Wuxi Biologics Cayman Inc
  Stock Data: Recent Stock Performance:
  Current Price (3/9/2018): 64.05
(Figures in Hong Kong Dollars)
1 Week 18.0%   13 Weeks 30.8%  
4 Weeks 49.0%   52 Weeks n/a  
Wuxi Biologics Cayman Inc Key Data:
  Ticker: 2269 Country: China
  Exchanges: HKG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 1,153,761,670
(Year Ending Jan 2017).
Employees: 1,624
  Currency: Hong Kong Dollars Market Cap: 74,646,007,989
  Fiscal Yr Ends: December Shares Outstanding: 1,165,433,380
  Share Type: ORDINARY Closely Held Shares: 784,458,296
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.